Viewing Study NCT03463733


Ignite Creation Date: 2025-12-25 @ 2:45 AM
Ignite Modification Date: 2026-02-07 @ 9:48 AM
Study NCT ID: NCT03463733
Status: UNKNOWN
Last Update Posted: 2020-10-08
First Post: 2018-03-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Hydroxy-urea and Temozolomide in Patients With a Recurrent Malignant Brain Tumor (Glioblastoma)
Sponsor: M.E. van Linde
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Glioma View
None Glioblastoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Glioma View
None Recurrent glioma View
None Glioblastoma multiforme View
None Recurrent Glioblastoma multiforme View
None Hydroxyurea View
None Temozolomide View